Michael Gladstone, Director at Day One Biopharmaceuticals, Inc. (DAWN), bought 766,667 shares at $15.00 ($11.5M) on 2022-06-17, disclosed to the SEC on 2022-06-22.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.